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838Objectives: The success of endovascular therapies for descending thoracic aortic disease has turned attention
toward stent graft options for repair of aortic arch aneurysms. Defining the role of such techniques demands un-
derstanding of contemporary results of open surgery.
Methods: The outcomes of open arch procedures performed on a single surgical service from July 1, 2001 to
August 30, 2010, were examined as defined per The Society of Thoracic Surgeons national database.
Results: During the study period, 209 patients (median age, 65 years; range, 26-88) underwent arch operations,
of which 159 were elective procedures. In 65 the entire arch was replaced, 22 of whom had portions of the de-
scending thoracic aorta simultaneously replaced via bilateral thoracosternotomy. Antegrade cerebral perfusion
was used in 78 patients and retrograde cerebral perfusion in 1. Operative mortality was 2.5% in elective circum-
stances and 10% in emergency cases (P ¼ .04). The stroke rate was 5.0% when procedures were performed
electively and 11.8% when on an emergency basis (P ¼ .11). Procedure-specific mortality rates were 5.5%
for elective and 10% for emergency procedures with total arch replacement, and 1.0% for elective and
10% for emergency procedures with hemiarch replacement. Stratified by extent, neurologic event rates were
5.5% for elective and 10% for emergency procedures with total arch and 4.8% for elective and 12.5% for emer-
gency procedures with hemiarch replacement.
Conclusions: Open aortic arch replacement can be performed with low operative mortality and stroke rates,
especially in elective circumstances, by a team with particular focus on the procedure. The results of novel
endovascular therapies should be benchmarked against contemporary open series performed in such a setting.
(J Thorac Cardiovasc Surg 2012;144:838-44)Open surgical replacement of the aortic arch is an infre-
quently performed procedure in most practices. It is techni-
cally complex, particularly from a perfusion standpoint,
demanding close cooperation and effective communication
among all members of the surgical team. Additionally, the
patient substrate requiring the procedure typically exhibits
advanced cardiovascular disease, increasing the operative
risk further. Because of these challenges and the success
demonstrated with endovascular stent grafting of other aor-
tic diseases in patients at high risk for open repair, endovas-
cular approaches to the arch are being explored as an
alternative to open repair.1-3 At the same time, the results
of open surgical repair of arch disease have improved
significantly with focused attention to the surgical,
anesthetic, and perfusion-related challenges, as well as the
introduction of selective antegrade cerebral perfusion
(SACP), modern graft materials, and technical modifica-
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The Journal of Thoracic and Cardiovascular Surgexamination of the subject documented an improvement
in results over time, presumably as a result of the
adoption of these techniques.4 Interpretation of this work,
however, was complicated by the technical preferences of
various individual surgeons performing the procedures.
Therefore, to more precisely determine the risk of the pro-
cedure when approached by a team with particular focus on
these procedures, we reviewed our results with open aortic
arch replacement performed over the past decade on a single
surgical service.PATIENTS AND METHODS
Consecutive patients who underwent reconstruction of the aortic arch by
1 surgeon (T.M.S.) at the Mayo Clinic, Rochester, Minnesota, from July 1,
2001, to August 30, 2010, were included in the study. Preoperative vari-
ables and postoperative outcomes were recorded prospectively as per
The Society for Thoracic Surgeons criteria. This computerized database
was retrospectively reviewed with the approval of the Mayo Clinic Institu-
tional Review Board with waiver of study-specific informed consent. We
focused on perioperative mortality (defined as within 30 days of primary
surgery or during the same hospital admission) and cerebrovascular events
as primary outcomes. Secondary outcomes included other complications
such as re-exploration for bleeding, renal failure, prolonged ventilation
(>48 hours), as well as surrogates for morbidity including length of hospi-
tal stay, 30-day readmission, and 5-year survivals.
Surgical Technique
Our technique for aortic arch surgery has evolved somewhat over time
as detailed in a previous study, with increasing adoption of axillary artery
cannulation in particular.4 Currently, patients with atherosclerotic disease,ery c October 2012
Abbreviations and Acronyms
DHCA ¼ deep hypothermic circulatory arrest
SACP ¼ selective antegrade cerebral perfusion
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Das opposed to that associated with connective tissue disease or bicuspid aor-
tic valve, are most often cannulated for arterial inflow via the axillary artery
using an 8-mm Dacron (DuPont, Wilmington, Del) graft regardless of the
extent of planned repair (total or hemiarch replacement). Despite the trend
toward lesser degrees of systemic cooling, we have persisted in cooling the
patient for a minimum period of 30 minutes and toward a target nasopha-
ryngeal temperature of 18C.
To ensure adequate neuroprotection, we initially used formal electroen-
cephalography, although we now rely on the bihemispheral processed en-
cephalogram. If an isoelectric state has not been achieved by 45 minutes
of cooling, intravenous barbiturates are administered. Barbiturates are
not otherwise routinely administered. Given a lack of convincing data
that outcomes are actually improved with the use of near-infrared spectros-
copy, we have not used this technology. To ensure adequate corporeal pro-
tection when total arch replacement in planned, we prefer to achieve
a bladder temperature less than 23C. In the case of hemiarch replacement,
a core temperature of 25C and 30 minutes of cooling is considered accept-
able given an expectation of a short arrest time. Acid–base management is
performed with pH-stat strategy during cooling and alpha-stat during
rewarming.
Selective antegrade cerebral perfusion is routinely used as an adjunct to
hypothermia for total arch replacement and in some instances of hemiarch
replacement. This is typically instituted unilateral initially taking advan-
tage of the right axillary artery inflow while branch graft reconstruction
of the brachiocephalic vessels is completed adherent to the ‘‘arch first’’
concept advocated by Kouchoukos’ group7 and others.8,9 Antegrade
perfusion of all vessels can thereby be restored promptly and before
construction of distal anastomoses. The initial flow is 10 mL $ kg1 $
min1 and is increased after restoration of antegrade flow in the left
subclavian to achieve a left radial artery pressure of 50 mm Hg. Like
others,10,11 we have not individually cannulated the brachiocephalic
vessels for SACP in favor of keeping the operative field uncluttered.
Stump pressures in the ipsilateral brachiocephalic and left carotid
arteries are measured with balloon catheters if prolonged hypothermia is
anticipated. We have largely abandoned retrograde cerebral perfusion
and use it only for the purpose of flushing debris from the head. This
technique was used in only 1 patient in this series.
Patient Demographics
As shown in Table 1, of 209 patients undergoing arch surgery during the
study period, there were 131 men and 78 women with a median age of 64.5
years (range, 26-88 years). Three quarters of the procedures (n¼ 159) were
elective. The most common diseases were degenerative aneurysms includ-
ing bicuspid aortic valve disease (124; 59%) followed by chronic (36;
17%) and acute (28; 13%) dissections. About a third of the patients
(n ¼ 69) had previous cardiac surgery. Significant risk factors for postop-
erative morbidity included hypertension in 70%; history of smoking in
62%; congestive heart failure New York Heart Association class III or
greater in 27%; chronic lung disease in 16%; previous history of stroke
or transient ischemic attack in 10%; peripheral vascular disease in 15%;
diabetes mellitus in 9%; hypercholesterolemia in 32%; and renal failure
in 4%. The mean body mass index was 27.9  5.8.
Operative Procedures
In more than two thirds of cases (n ¼ 104, 72%), the replacement was
hemiarch in extent (Table 2). In cases of hemiarch replacement, theThe Journal of Thoracic and Caunderside of the aortic arch was resected in all instances well beyond the
level of the takeoff of the innominate artery to a point opposite the takeoff
of the subclavian artery. In 22 of the total arch cases, the descending tho-
racic aorta was concomitantly replaced via bilateral thoracosternotomy.
An elephant trunk procedure was performed in 27 (13%) patients. In
83% of the patients undergoing total arch repairs, the axillary artery was
cannulated whereas the femoral artery (8%) or central aorta (9%) was
equally cannulated in the rest. In half of the hemiarch patients, the central
aorta was cannulated followed by the axillary artery in 39% and the fem-
oral artery in 10%. Selective antegrade cerebral perfusion was used in 78
(37%) patients, including all of the total arch patients. Aortic root replace-
ment was the most commonly performed concomitant procedure (41%),
whereas the aortic valve was replaced in 11% and coronary artery bypass
grafting performed in 22%.
The total bypass time (see Table 3 for operative times) for total arch re-
placement was longer than that for hemiarch replacement by approxi-
mately 1 hour (225 vs 165 minutes; P< .001), although this is affected
by the number of patients undergoing concomitant replacement of the de-
scending thoracic aorta. With the use of SACP, cerebral circulatory arrest
times for total arch replacement were not dissimilar to those for hemiarch
replacement (23 vs 20 minutes; P ¼ .79), despite corporeal arrest times
over an hour in the case of total arch surgery.
Statistical Analysis Method
Descriptive statistics for categorical variables are reported as frequency
and percentage whereas continuous variables are reported as mean (stan-
dard deviation) or median (range) as appropriate. Categorical variables
were compared between hemiarches and total arches using the c2 test or
Fisher exact test and continuous variables were compared using the
2-sample t test or Wilcoxon rank sum test where appropriate. All statistical
tests were 2-sided with the alpha level set at .05 for statistical significance.
RESULTS
Perioperative mortality occurred in 9 (4.3%) patients.
Patients undergoing emergency procedures had almost
a 4-fold greater mortality rate (10%) than those undergoing
elective procedures (2.5%) (P ¼ .04). When stratified by
the extent of repair and urgency, there were 3 (5.5%) deaths
among those undergoing elective total arch replacement and
1 (1.0%) among those undergoing elective hemiarch
replacement (P ¼ .12). Of the 5 deaths in the hemiarch re-
placement patients, 4 were in the setting of acute dissection.
There were no deaths or neurologic complications in any of
the hemiarch patients who had SACP. Of the total arch pa-
tients, all of whom had SACP, 4 (6.3%) had a stroke, even-
tually resulting in their death. A significant burden of risk
was among those undergoing replacement of the arch and
descending thoracic aorta via thoracosternotomy, with 3
deaths and 3 strokes among these 22 patients (13.6%
each). Conversely, among the total arches excluding these
very high-risk patients, the mortality rate and stroke rate
were 2% each.
The most common cause of perioperative death was
stroke, which occurred in 4 patients (3 ischemic and 1 hem-
orrhagic). Other causes included postoperative heart failure
(n¼ 1), rupture of the descending thoracic aorta after repair
of an acute dissection related to severe labile hypertension
(n ¼ 1), and renal failure (n ¼ 1). Two patients died at
home after discharge from the hospital on postoperativerdiovascular Surgery c Volume 144, Number 4 839
TABLE 1. Patient demographics
Variable All arch (n ¼ 209) Total arch (n ¼ 65) Hemiarch (n ¼ 144) P value
Median age, y (range) 65 (26-88) 63 (27-88) 63 (27-88) .362
Gender, male (%) 131 (63) 36 (55) 95 (66) .143
Etiology (missing) (5) (2) (3)
Degenerative (%) 124 (59) 35 (54) 89 (62) .278
Acute dissection (%) 28 (13) 1 (2) 27 (19) <.001
Chronic dissection (%) 36 (17) 17 (26) 19 (13) .022
Marfan syndrome (%) 9 (4) 5 (8) 4 (3) .105
Mycotic pseudoaneurysm (%) 6 (3) 5 (8) 1 (1) .005
Other (%) 1 (0.5) 0 1 (1) .036
Comorbidities
BMI 27.1 (17.3-63.9) 26.4 (19.1-43.0) 27.7 (17.3-63.9) .077
Smoking (%) 129 (62) 42 (65) 87 (60) .563
Renal failure (%) 7 (3) 2 (3) 5 (3) .760
Diabetes mellitus (%) 18 (9) 6 (9) 12 (8) .831
Hypertension (%) 149 (71) 47 (72) 102 (71) .827
Prior stroke (%) 21 (10) 7 (11) 14 (14) .940
Prior MI (%) 11 (5) 1 (2) 10 (7) .068
Prior cardiac surgery (%) 69 (33) 27 (42) 42 (29) .078
Chronic lung disease (moderate to severe) (%) 13 (6) 6 (9) 7 (5) .226
PVD (%) 31 (15) 15 (23) 16 (11) .024
EF<40 (%) 6 (3) 2 (3) 4 (3) .984
Hypercholesterolemia (%) 67 (26) 23 (35) 43 (30) .909
BMI, Body mass index; MI, myocardial infarction; PVD, peripheral vascular disease; EF, ejection fraction.
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Ddays 15 and 26, respectively, and the causes of their death
could not be determined. One of these patients had a perio-
perative stroke.
Neurologic complications occurred in 14 patients (over-
all, 6.7%; elective procedures, 5.0%). These included
strokes in 13 patients and a transient ischemic attack in 1.
All strokes were confirmed by computed tomography orTABLE 2. Operative variables
Variable Total Total arch Hemiarch
P
value
Elective (%) 159 (76.1) 55 (84.6) 104 (72.2) .052
Selective cerebral perfusion <.001
None (%) 132 (63.2) 0 (0) 127 (88.2) <.001
SACP (%) 78 (37.3) 65 (100) 13 (9) <.001
RCP (%) 1 (0.5) 0 (0) 1 (1) .501
Arterial cannulation
Central aorta (%) 80 (38) 6 (9) 74 (51) <.001
Femoral artery (%) 19 (9) 5 (8) 14 (10) .637
Axillary artery (%) 110 (53) 54 (83) 56 (39) <.001
Other procedures
AVR (%) 23 (11) 8 (12) 15 (10) .686
Aortic root (%) 86 (41) 18 (28) 68 (47) .008
CABG (%) 46 (22) 18 (28) 28 (19) .183
MVR/repair (%) 5 (2) 1 (1.5) 3 (2) .790
TV (%) 2 (1) 0 (0) 1 (1) .340
ASD (%) 15 (7) 3 (5) 12 (8.3) .335
SACP, Selective antegrade cerebral perfusion; RCP, retrograde cerebral perfusion;
AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVR, mitral
valve replacement; TV, tricuspid valve procedure; ASD, atrial septal defect repair.
840 The Journal of Thoracic and Cardiovascular Surgmagnetic resonance imaging if the computed tomographic
scan was indeterminate. On the basis of these studies, 12 ap-
peared ischemic or embolic and 1 was hemorrhagic. The
rate of stroke in patients undergoing emergency replace-
ments (11.8%) was over twice that of patients whose oper-
ations were performed on an elective basis (5.0%)
(P ¼ .11). Stroke rates were similar in the hemiarch
(6.9%) and total arch (6.2%) cohorts (P ¼ .83). Of the 9
strokes in the hemiarch replacement patients, 3 were in
the setting of acute dissection, 4 atherosclerotic aneurysm,
and 1 each in the setting of endocardits and chronic dissec-
tion. The 1 patient who had a transient ischemic attack had
undergone a hemiarch replacement for aneurysm.
Although the source of embolic material is a matter of
conjecture, retrograde embolization from femoral artery
cannulation was suspected in 3 of the 5 patients with stroke
who had femoral cannulation for arterial inflow as imaging
was highly suggestive of embolic etiology. In 1 patient the
stroke appeared ischemic, and in 1 patient ischemic versus
embolic etiology could not be adequately determined al-
though carotid ultrasonography and magnetic resonance an-
giography were negative for any significant stenosis. The
stroke rate associated with femoral cannulation, then, was
5 of 19 or 26%. This also represents half of the hemiarch
patients who had postoperative neurologic complications.
These observations accounted in part for our shift over
time to axillary cannulation as the preferred perfusion tech-
nique in the presence of atherosclerotic disease. With regard
to the 7 patients who had a stroke despite axillaryery c October 2012
TABLE 3. Operative times
Variable, min;
mean (range) All arch Total arch Hemiarch
P
value
Corporeal CA 38.4 (9-130) 74.2 (32-130) 21.8 (9-86) <.001
Cerebral CA 21.1 (3-72) 23.2 (3-72) 19.7 (3-56) .793
ACC 110.3 (7-236) 126.4 (7-236) 102.9 (24-221) <.001
CPB 183.8 (88-378) 224.8 (143-378) 165.3 (88-306) <.001
CA, Circulatory arrest time; ACC, aortic crossclamp time; CPB, cardiopulmonary
bypass.
TABLE 4. Postoperative complications and length of stay
Complication
All
arch
Total
arch Hemiarch
P
value
Reoperation for bleeding (%) 16 (8) 11 (17) 5 (4) .001
Neurologic deficit (%) 14 (6) 4 (6) 10 (7) .832
Prolonged ventilation
>48 h (%)
24 (12) 14 (22) 10 (7) .002
Renal failure (%) 6 (3) 3 (5) 3 (2) .310
Death (%) 9 (4) 4 (6) 5 (3) .377
Readmit<30 d (%) 28 (1) 6 (9) 22 (15) .260
LOS, d; mean (range) 8.9 (3-34) 10.9 (5-31) 7.6 (3-34) <.001
LOS, Length of stay.
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Dcannulation, 1 had hemorrhagic stroke, 3 had embolic pat-
terns, 2 ischemic patterns, and in 1 the radiologic appear-
ance was nonspecific. The appearance of the magnetic
resonance imaging scan was nonspecific between ischemia
versus embolism for the 1 patient who had central cannula-
tion and stroke.
Postoperative bleeding requiring reoperation occurred in
16 (7.6%) patients as shown in Table 4. The mean postop-
erative ventilator timewas 36 hours. Mechanical ventilation
was required for more than 48 hours in 24 (11.5%) patients,
of whom 11 (46%) had undergone a ‘‘clamshell’’ incision.
Renal failure requiring dialysis occurred in 6 (3%) patients.
Among patients surviving to discharge, the mean length of
hospital stay was 8.6  5.2 days (range, 3-34 days). Read-
mission within 30 days of primary operation occurred in 28
(13%) patients for various reasons.DISCUSSION
Historically, open surgical replacement of the aortic arch
has carried a significant risk, with perioperative mortality
rates from 7% to 12% reported for elective cases11,12 and
even higher under emergency circumstances.13 There
has been, however, a significant improvement in results
over time4,14; despite this, there remains significant
apprehension over subjecting a patient to these
procedures. Although the volume of cases reported here is
quite modest compared with those reported from many
Asian and European centers of excellence, our study does
show that with a focus on aortic disease using
contemporary techniques, one can perform open aortic
arch surgery with considerably lower perioperative
mortality and morbidity than was historically the case,
particularly under elective circumstances. Such
contemporary results should be used as a comparator to
hybrid repairs when trying to determine the place of each
of these complementary therapies in current practice.
Accordingly, although advances in endovascular
techniques offer great promise for reducing further the
morbidity associated with open surgery, open repair
should remain a part of our armamentarium, particularly
for younger, lower-risk patients and those with complex
anatomy or connective tissue disorders.
Although overall the results are encouraging, the out-
comes observed with bilateral thoracosternotomy wereThe Journal of Thoracic and Caless gratifying than other total arch patients and raise ques-
tions about the place of this approach vis-a-vis elephant
trunk type procedures, be they open or ‘‘frozen.’’ The num-
ber of patients in this subgroup is too small to allow defin-
itive conclusions and the spectrum of disease is broad, from
congenital anomalies to extensive atherosclerotic disease. It
is our impression that the operation is well tolerated and is,
in fact, preferable in younger patients and those with com-
plex anatomy such as cervical arch with coarctation or com-
plex dissection. The results are less appealing, but options
are also less, in those with mega-aorta owing to atheroscle-
rotic disease. These individuals often have no distal landing
zone, although current progress with fenestrated endograft
technology is certainly advancing capabilities in this area.
We, too, would agree that serious consideration should be
given to treating such patients endovascularly if possible.
Our results are consistent with those reported by others
with particular focus on aortic disease. The Mount Sinai
group, also relying on a combination of deep hypothermia
and SACP via the axillary artery, has observed improved re-
sults after open arch surgery over time.14 Their recently re-
ported mortality rate for total arch replacement was 6.8%,
very similar to our results with total arch replacement
(6.3%).5 This improvement in outcome over time with
the adoption of cerebral protective strategies is not limited
to the low-risk population as demonstrated by Minatoya
and associates15 who reported results of arch surgery in oc-
togenarians from 1995 to 2007. In this series, among elec-
tive cases, the overall mortality rate was 7.9% with
a significant decrease in mortality (4.5%) toward the later
half of their study period subsequent to the adoption of sim-
ilar brain protection strategy to ours. It must be noted, how-
ever, that in expert hands and a focus on aortic disease, Gega
and colleagues16 achieved commendable results with deep
hypothermia and circulatory arrest (DHCA) alone, report-
ing a mortality rate of only 3.6% for elective cases.
The basis for this improvement over time is likely multi-
factorial. In addition to specific technical modifications,
there are likely other aspects of the ‘‘learning curve,’’ the re-
sults of which are observed with many surgical procedures
and likely include focused attention to various aspect ofrdiovascular Surgery c Volume 144, Number 4 841
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fusion and anesthesia practices. We acknowledge some
changes in our own practice over time, including an increas-
ing aversion to femoral cannulation for arterial inflow be-
cause of concern about neurologic complications, as
noted. In addition, conduct of hypothermic circulatory arrest
is nontrivial from an anesthetic and perfusion standpoint.
During the study interval, the use of DHCA in our institution
increased significantly, leading to the formal adoption of
perfusion protocols that had not been previously codified.
Our belief is that improved cerebral protection has reduced
postoperative neurologic injury,4 which in turn has been
shown to reduce mortality.17 Indeed, most common single
cause for mortality in our series was severe stroke, and we
have increasingly come to recognize preventing neurologic
injury as a critical objective in aortic arch surgery. We
openly acknowledge tardiness in adopting some adjuncts
such as SACP and axillary cannulation as compared with
our European and Asian colleagues. Had we been more
open, wemight have improved our results early in the series.
We continue to rely on hypothermia as our primary neu-
roprotective strategy and to regard SACP as an adjunct, not
a substitute. This is particularly the case for those patients in
whom only a brief episode of circulatory arrest is antici-
pated, as argued by others.16 The virtues of SACP during
periods of circulatory arrest lasting more than 30 minutes
are well demonstrated in maintaining cerebral oxygenation
and reducing derangements in cerebral metabolism.18-20
We4 have also previously demonstrated that, in cases with
corporeal arrest times over 30minutes, SACP ‘‘neutralizes’’
the impact of arrest time on stroke and mortality. The addi-
tion of axillary cannulation, which not only simplifies the
surgical field but also directs flow (and embolic debris) ret-
rogradely out of the innominate artery, has been shown by
others to significantly reduce the mortality and morbidity
after aortic arch repairs, especially in elective circum-
stances.11 As we have embraced Kouchoukos’s ‘‘arch first’’
philosophy, the use of the axillary artery for antegrade per-
fusion also allows us to resume cerebral perfusion via all
vessels as soon as the arch vessels are reconstructed, permit-
ting time for unhurried distal reconstructions without fear of
cerebral ischemia.
Despite the current trend toward combining SACP with
only moderate hypothermia, we have been quite satisfied
with our results using profound cooling and circulatory ar-
rest. We cool for a minimum of 30 minutes to ensure even
cooling. Estimation of brain temperature at surrogate sites
may not be accurate21,22; thus, even if the target core
temperature is reached early, the extra cooling time helps
ensure adequate hypothermia at cellular levels.22,23 This
may be responsible in part for our very infrequent
observation of ‘‘transient neurologic dysfunction.’’
We have been reluctant to surrender the protective effects
of hypothermia to the viscera as well. Renal–mesenteric842 The Journal of Thoracic and Cardiovascular Surgischemia has been shown to be a determinant of early death
after DHCA.12,17 None of our patients had mesenteric
ischemia and only 6 (3%) of our patients had renal failure
requiring dialysis. At an institutional level, we have not
found DHCA to increase the risk of acute renal injury in
thoracic aortic surgery.24 We acknowledge that other au-
thors25-28 have suggested that rates of other complications
are higher with DHCA, but we have not found this to be
the case. The group at Emory University advocates
moderate hypothermic circulatory arrest with unilateral
SACP as conferring adequate cerebral protection during
arch repairs while avoiding the disadvantages of DHCA.
In their series of 412 patients, the mortality rate was 7%,
overall neurologic events occurred in 8.7%, and renal
dysfunction was 4.6% with no apparent relationship to
arrest temperature.29 Although a direct comparison with
the Emory patient population has limitations for many rea-
sons, the advantages of only moderate hypothermia are un-
convincing to us inasmuch as there do not appear to be
significant reductions in mean cardiopulmonary bypass
time or reoperation for bleeding with their approach as com-
pared with our study, and the time to discharge was actually
somewhat shorter in our study (8.6  5.6 days compared
with the Emory group 10.3  7.5 days). Further, the Emory
group’s excellent results with moderate hypothermia are not
universally observed. Khaladj and associates30 reported
a concerning mortality rate of 11.6% and total (permanent
and temporary) neurologic event rate of 22%, even with the
use of SACP, in a series of 501 patients undergoing arch re-
pairs with moderate hypothermic arrest. We have been par-
ticularly concerned about the adequacy of contralateral
cerebral perfusion on the basis of our previously reported
observations of stump pressures when inflow is via the right
axillary artery, a concern that is only heightened at moder-
ate perfusion temperatures.4
The principal utility of a study such as this hinges on its
implications for selecting, for a specific patient, among the
ever-expanding range of options for the treatment of aortic
disease. The overall mortality rates recently reported for hy-
brid aortic arch surgery have ranged from 3.2% to 19% and
stroke rates from 0% to 6.3%.1,2,31-33 In a recent meta-
analysis of hybrid aortic arch surgery in 463 patients, the
30-day mortality rate was reported to be 8.3% and stroke
rate, 4.4%.31 Of course, as is the case for open repair, the
results obtained will be critically dependent not only on
the technique, but also on the patient substrate. Although
they found no significant differences in overall mortality,
stroke rates, or long-term survival between the hybrid and
open groups, Milewski and colleagues2 from the Hospital
of the University of Pennsylvania have advocated a hybrid
approach for patients greater than 75 years inasmuch as
the mortality rate in their experience for open surgery in
this age group was 36%. This is, however, significantly
higher than the mortality rate we observed in our seriesery c October 2012
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hybrid stent-graft group had a rate of temporary spinal cord
ischemia of 11%, a complication we have not observed in
any of our cases including the thoracosternotomy patients,
and far higher than has been reported for staged repair of
thoracic aortic aneurysms using the classic elephant trunk
technique.34 In a separate report, the same group reported
mortality and stroke rates for stented aortic arch grafts as
high as 11% each.3 Although such outcomes may be ap-
pealing in some patients, such as those with extensive
arch and descending thoracic disease, as was the case for
many of the patients who underwent operation in our series
via bilateral thoracosternotomy, for others it would likely be
unacceptable.
Additional concerns about the endovascular approach in-
clude the lack of long-term results including reintervention
and other complications, particularly for younger patients
and those with connective tissue disease. The need for
long-term surveillance after hybrid repairs is also
a disadvantage.
Study Limitations
The current study has limitations inherent to retrospective
studies. Selection bias and referral bias are significant ever
present in surgical series, particularly in light of our study
design, which reflects the practice of only 1 surgeon. The
comparison with hybrid repairs is flawed as well, inasmuch
as the extent of repair differs. A comparison with elephant
trunk patients who underwent second stage repair might
be more equitable, but the numbers in this instance would
be too small to bemeaningful. The ideal would be to conduct
a prospective randomized study to compare hybrid with
open procedures, but this does not seem imminent inasmuch
there are significant limitations to the application of hybrid
surgery and selection bias here too is unavoidable. Underre-
porting of late complications may result in ascertainment
bias because a number of our patients are referred from dis-
tant centers and may have returned to their local hospital for
postoperative issues after discharge. However, we make an
effort to maintain communication and our providers are typ-
ically informed regarding such problems and document tele-
phone calls. The more important question is whether our
results can be generalized to all practice settings.
CONCLUSIONS
In summary, recent results of open aortic arch surgery,
particularly under elective circumstances, are excellent
when appropriate principles of neurologic and corporeal
protection are followed. Accordingly, for the foreseeable
future, there should continue to be a place for open surgical
repair in appropriately selected patients. Although new
technologies are welcomed, they should be considered
complementary to open repair, and their place should be
determined by comparison with current results andThe Journal of Thoracic and Cacontemporary open techniques. Inasmuch as aortic arch dis-
ease is relatively uncommon, consideration of referral to
high-volume centers in which all options are available
should be considered.References
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